Charles Schwab’s Oncorus, Inc. ONCR Stock Holding History

Charles Schwab’s Portfolio ONCR Stock Details ONCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-43,295	Closed	-$78K	–	3691
2022 Q1	$78K	Hold	43,295	–	–	﹤0.01%	3461
2021 Q4	$229K	Hold	43,295	–	–	﹤0.01%	3340
2021 Q3	$405K	Sell	43,295 -40,198	-48%	-$459K	﹤0.01%	3203
2021 Q2	$1.15M	Buy	83,493 +25,477	+44%	+$394K	﹤0.01%	2878
2021 Q1	$808K	Buy	58,016 +19,063	+49%	+$395K	﹤0.01%	2923
2020 Q4	$1.26M	Buy	+38,953	New	+$902K	﹤0.01%	2710

Other funds holding ONCR

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Charles Schwab's ONCR Position: Q2 2022 in Review

Charles Schwab sold out of Oncorus, Inc. (ONCR) in Q2 2022, closing a stake of 43,295 shares — an estimated $78K sold.

Charles Schwab first reported a position in ONCR in Q4 2020 and held it in 6 quarters. The position peaked at $1.26M in Q4 2020. 45 funds tracked by Wall St. Rank hold ONCR as of Q2 2022.

Charles Schwab reported no remaining Oncorus, Inc. position as of Q2 2022 after selling out during the quarter.
Charles Schwab sold 43,295 Oncorus, Inc. shares in Q2 2022, an estimated $78K.
Charles Schwab first reported a position in Oncorus, Inc. in Q4 2020 and held it in 6 quarters.
Charles Schwab's Oncorus, Inc. position peaked at $1.26M in Q4 2020.
45 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q2 2022.

Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.